News
News
Closing Bell: ASX up as unemployment rate ticks higher; BHP, Nimy Resources gain
Health & Biotech
Weed Week: A VAST majority of Americans now want marijuana to be legal
Health & Biotech
Neurotech’s Phase 2/3 autism trial meets primary endpoint
Health & Biotech
Melodiol unaudited revenue up 79% in Q1 FY24
News
Closing Bell: ASX crushed with all 11 sectors deep in the red, but there’s some good news from China
Health & Biotech
Bioxyne subsidiary granted upgraded wholesale licence for MDMA and psilocybin finished products
Health & Biotech
Neurotech hits new milestone in Phase II/III autism trial after treating last patient
Health & Biotech
Melodiol welcomes Chuck’s petition to pass US SAFER Banking Act
Health & Biotech
Melodiol’s Mernova gains more traction in Canada: revenues increase, new products launched
News
Closing Bell: ASX rebounds as soft CPI bolsters August rate cut hopes; OSX and TLM lead today’s winners
Health & Biotech
Melodiol subsidiaries contribute $3.1 million revenue in first two months of 2024
Health & Biotech
Dr Boreham’s Crucible: Vitura Health is the tall poppy in a paddock of weed
Health & Biotech
‘Tide is turning for the healthcare sector’ – ASX biotechs making strong gains in 2024 Part 2
Health & Biotech
Neurotech extends clinical trials for the $US2bn Rett Syndrome market
Health & Biotech
Weed Week: Cannabis can ‘kill melanoma’; and Germany legalises weed possession
News
Rise and Shine: Everything you need to know before the ASX opens
News